Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)

NEXT STORY
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
PREV STORY
Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval

author_avatar
NASDAQ Market News

Loxo Oncology to Announce First Quarter 2017 Financial Results

STAMFORD, Conn., May 02, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

SOT101 Shows Clinical Benefit in Patients with Advanced Solid Tumors

author_avatar
NASDAQ Market News